Total Payments
$160,695
2024 Payments
$52,339
Companies
15
Transactions
267
Medicare Patients
7,160
Medicare Billing
$809,418
Payment Breakdown by Category
Consulting$128,657 (80.1%)
Other$18,249 (11.4%)
Travel$7,520 (4.7%)
Food & Beverage$6,269 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $128,657 | 131 | 80.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,150 | 4 | 7.6% |
| Travel and Lodging | $7,520 | 29 | 4.7% |
| Food and Beverage | $6,269 | 101 | 3.9% |
| Grant | $6,000 | 1 | 3.7% |
| Entertainment | $99.13 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $119,105 | 148 | $0 (2024) |
| Medtronic Vascular, Inc. | $16,906 | 64 | $0 (2019) |
| BIOTRONIK INC. | $6,499 | 7 | $0 (2024) |
| ZOLL Respicardia, Inc. | $4,650 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,946 | 2 | $0 (2018) |
| Abbott Laboratories | $2,891 | 22 | $0 (2024) |
| Preventice Services, LLC | $2,678 | 3 | $0 (2019) |
| Respicardia, Inc. | $2,295 | 3 | $0 (2020) |
| Terumo Medical Corporation | $500.00 | 1 | $0 (2017) |
| Biosense Webster, Inc. | $488.98 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52,339 | 64 | Boston Scientific Corporation ($42,582) |
| 2023 | $29,816 | 42 | Boston Scientific Corporation ($25,888) |
| 2022 | $36,663 | 43 | BOSTON SCIENTIFIC CORPORATION ($35,613) |
| 2021 | $7,844 | 11 | BOSTON SCIENTIFIC CORPORATION ($7,721) |
| 2020 | $3,132 | 7 | Boston Scientific Corporation ($2,382) |
| 2019 | $6,954 | 22 | Medtronic Vascular, Inc. ($4,229) |
| 2018 | $9,634 | 31 | Novartis Pharmaceuticals Corporation ($3,736) |
| 2017 | $14,312 | 47 | Medtronic Vascular, Inc. ($11,807) |
All Payment Transactions
267 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $99.13 | General |
| Category: Electrophysiology | ||||||
| 11/07/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 11/07/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 11/07/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 11/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $99.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/02/2024 | Stereotaxis Inc | Genesis (Device) | Entertainment | Cash or cash equivalent | $99.13 | General |
| Category: Cardiac | ||||||
| 11/01/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 11/01/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 11/01/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 10/12/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $7,400.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 10/10/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 10/10/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Clinical Trial Product_CRM | ||||||
| 09/26/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $211.20 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/26/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $199.71 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/26/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $188.10 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/26/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $112.07 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/26/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/24/2024 | BIOTRONIK INC. | — | Grant | Cash or cash equivalent | $6,000.00 | General |
| 09/24/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $305.03 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/11/2024 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $9.78 | General |
| 09/10/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $99.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $56.19 | General |
| 09/03/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $248.20 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 1,987 | 2,565 | $1.5M | $199,610 |
| 2022 | 34 | 2,077 | 2,726 | $1.5M | $234,069 |
| 2021 | 34 | 1,597 | 2,384 | $1.2M | $203,848 |
| 2020 | 34 | 1,499 | 1,963 | $907,925 | $171,890 |
Total Patients
7,160
Total Services
9,638
Medicare Billing
$809,418
Procedure Codes
158
All Medicare Procedures & Services
158 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 30 | 30 | $149,850 | $27,353 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 198 | $84,150 | $21,063 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 110 | $60,500 | $16,625 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 71 | 71 | $49,700 | $13,442 | 27.0% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 16 | 16 | $61,040 | $12,874 | 21.1% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 24 | 24 | $90,000 | $11,404 | 12.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 53 | $34,450 | $8,092 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $26,775 | $7,411 | 27.7% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 23 | 23 | $41,400 | $6,784 | 16.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 62 | $21,700 | $6,620 | 30.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 192 | 273 | $34,125 | $5,759 | 16.9% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 17 | 17 | $26,350 | $5,014 | 19.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 142 | 160 | $20,000 | $4,227 | 21.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 62 | 209 | $20,900 | $4,026 | 19.3% |
| 93623 | Programming of heart rhythm stimulation after drug infusion | Facility | 2023 | 47 | 49 | $31,850 | $3,855 | 12.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 62 | 159 | $15,900 | $3,754 | 23.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 45 | 48 | $6,000 | $3,600 | 60.0% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 101 | 108 | $27,000 | $3,496 | 12.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 97 | 107 | $26,750 | $2,922 | 10.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 27 | 31 | $28,985 | $2,838 | 9.8% |
| 93462 | Insertion of tube in left heart chamber through heart septum | Facility | 2023 | 14 | 14 | $9,800 | $2,785 | 28.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 71 | 101 | $23,230 | $2,707 | 11.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 23 | 24 | $4,200 | $2,658 | 63.3% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2023 | 26 | 26 | $446,602 | $2,029 | 0.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 53 | 55 | $12,650 | $1,816 | 14.4% |
About Dr. Steven Markowitz, MD
Dr. Steven Markowitz, MD is a Cardiovascular Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467549535.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Markowitz, MD has received a total of $160,695 in payments from pharmaceutical and medical device companies, with $52,339 received in 2024. These payments were reported across 267 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($128,657).
As a Medicare-enrolled provider, Markowitz has provided services to 7,160 Medicare beneficiaries, totaling 9,638 services with total Medicare billing of $809,418. Data is available for 4 years (2020–2023), covering 158 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location New York, NY
- Active Since 10/09/2006
- Last Updated 07/04/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1467549535
Products in Payments
- Clinical Trial Product (Device) $35,888
- CLINICAL TRIAL PRODUCT (Device) $9,762
- remede System (Device) $6,945
- HSY244 (Drug) $3,736
- RHYTHMIA (Device) $2,207
- AVEIR (Device) $1,679
- Arctic Front (Device) $1,558
- Micra (Device) $1,339
- GENERAL - BRADY (Device) $1,333
- SelectSecure (Device) $874.55
- TENDRIL (Device) $575.00
- GENERAL BRADY (Device) $500.00
- GENERAL BRADY (Device) $375.00
- Sotalol Hydrochloride (Drug) $306.82
- GENERAL THERAPIES (Device) $254.71
- RhythmVIEW Work Stations (Device) $210.39
- MICRONY (Device) $194.45
- Acticor 7 VR-T DX (Device) $188.40
- CARTO 3 (Device) $178.42
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $152.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New York
Dr. Roger Hajjar, Md, MD
Cardiovascular Disease — Payments: $5.2M
Cardiovascular Disease $5.2M
Dr. Jacob Koruth, M.d, M.D
Cardiovascular Disease — Payments: $3.2M
Cardiovascular Disease $3.2M
Dr. Martin Leon, M.d, M.D
Cardiovascular Disease — Payments: $2.7M
Cardiovascular Disease $2.7M
Dr. Gregg Stone, M.d, M.D
Cardiovascular Disease — Payments: $2.2M
Cardiovascular Disease $2.2M
Adam Rosenbluth, Md, MD
Cardiovascular Disease — Payments: $1.5M
Cardiovascular Disease $1.5M
Dr. Deepak Bhatt, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M